Barclays PLC Anika Therapeutics, Inc. Transaction History
Barclays PLC
- $377 Billion
- Q3 2024
A detailed history of Barclays PLC transactions in Anika Therapeutics, Inc. stock. As of the latest transaction made, Barclays PLC holds 32,664 shares of ANIK stock, worth $530,136. This represents 0.0% of its overall portfolio holdings.
Number of Shares
32,664
Previous 32,664
-0.0%
Holding current value
$530,136
Previous $806,000
-0.0%
% of portfolio
0.0%
Previous 0.0%
Shares
29 transactions
Others Institutions Holding ANIK
# of Institutions
123Shares Held
11.5MCall Options Held
200Put Options Held
100-
Trigran Investments, Inc.2.12MShares$34.5 Million5.75% of portfolio
-
Black Rock Inc. New York, NY1.61MShares$26.1 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA799KShares$13 Million0.0% of portfolio
-
Dimensional Fund Advisors LP Austin, TX707KShares$11.5 Million0.0% of portfolio
-
Jim Simons Renaissance Technologies LLC | New York, Ny574KShares$9.32 Million0.02% of portfolio
About Anika Therapeutics, Inc.
- Ticker ANIK
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 14,599,900
- Market Cap $237M
- Description
- Anika Therapeutics, Inc., a joint preservation company, creates and delivers advancements in early intervention orthopedic care in the areas of osteoarthritis (OA) pain management, regenerative solutions, soft tissue repair, and bone preserving joint technologies in the United States, Europe, and internationally. The company develops, manufactur...